Neutral ceramidase-dependent regulation of macrophage metabolism directs intestinal immune homeostasis and controls enteric infection.
Neutral ceramidase-dependent regulation of macrophage metabolism directs intestinal immune homeostasis and controls enteric infection.
复制标题
DOI:
10.1016/j.celrep.2022.110560
复制
发表时间:
2022-03-29
期刊:
影响因子:
8.8
通讯作者:
Deng, Zhongbin
中科院分区:
文献类型:
--
作者:
Sun, Rui;Gu, Xuemei;Lei, Chao;Chen, Liang;Chu, Shenghui;Xu, Guangzhong;Doll, Mark A.;Tan, Yi;Feng, Wenke;Siskind, Leah;McClain, Craig J.;Deng, Zhongbin
It is not clear how the complex interactions between diet and intestinal immune cells protect the gut from infection. Neutral ceramidase (NcDase) plays a critical role in digesting dietary sphingolipids. We find that NcDase is an essential factor that controls intestinal immune cell dynamics. Mice lacking NcDase have reduced cluster of differentiation (CD) 8αβ+ T cells and interferon (IFN)-γ+ T cells and increased macrophages in the intestine and fail to clear bacteria after Citrobacter rodentium infection. Mechanistically, cellular NcDase or extracellular vesicle (EV)-related NcDase generates sphingosine, which promotes macrophage-driven Th1 immunity. Loss of NcDase influences sphingosine-controlled glycolytic metabolism in macrophages, which regulates the bactericidal activity of macrophages. Importantly, administration of dietary sphingomyelin and genetic deletion or pharmacological inhibition of SphK1 can protect against C. rodentium infection. Our findings demonstrate that sphingosine profoundly alters macrophage glycolytic metabolism, leading to intestinal macrophage activation and T cell polarization, which prevent pathogen colonization of the gut. Sun et al. find that neutral ceramidase sculpts the intestinal immune landscape and drives macrophage metabolic function and, consequently, glycolysis-dependent PP2A-controlled inflammasome activation, IL-1β production, and bactericidal activity of macrophages. These data describe an intestine-intrinsic interplay between sphingolipid metabolites and gut nutritional immunity against a mucosal pathogen.
登录
查看更多内容
影响因子:
30.5
作者:
通讯作者:
--
DOI:
10.1002/hep.31321
发表时间:
2021-03
期刊:
Hepatology (Baltimore, Md.)
影响因子:
--
作者:
Chu S;Sun R;Gu X;Chen L;Liu M;Guo H;Ju S;Vatsalya V;Feng W;McClain CJ;Deng Z
通讯作者:
Deng Z
影响因子:
29
作者:
Divakaruni AS;Hsieh WY;Minarrieta L;Duong TN;Kim KKO;Desousa BR;Andreyev AY;Bowman CE;Caradonna K;Dranka BP;Ferrick DA;Liesa M;Stiles L;Rogers GW;Braas D;Ciaraldi TP;Wolfgang MJ;Sparwasser T;Berod L;Bensinger SJ;Murphy AN
通讯作者:
Murphy AN
影响因子:
3.6
作者:
Duan, Rui-Dong;Cheng, Yajun;Nilsson, Ake
通讯作者:
Nilsson, Ake
DOI:
10.1002/hep.31628
发表时间:
2021-03
期刊:
Hepatology (Baltimore, Md.)
影响因子:
--
作者:
Gu X;Sun R;Chen L;Chu S;Doll MA;Li X;Feng W;Siskind L;McClain CJ;Deng Z
通讯作者:
Deng Z